QA: DYNAVAX TECHNOLOGIES CORP in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001029142_2022_DYNAVAX_TECHNOLOGIES_CORP.pdf

Logs

warning Ignoring company because Assets is zero pre-agg {'balance_sheet': {'company_id': '0001029142', 'EntityCommonStockSharesOutstanding': 124921757, 'Assets': 0, 'AssetsCurrent': 0, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 366294000, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 816872000, 'LiabilitiesAndStockholdersEquity': 1039246000, 'LiabilitiesCurrent': 556402000, 'LiabilitiesNoncurrent': 39980000, 'NetIncome': 76713000, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 32228000, 'Revenues': 447177000, 'SellingGeneralAndAdministrativeExpense': 100156000, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': -2539000, 'remainder_Expenses': 233910000, 'remainder_Liabilities': 220490000, 'remainder_LiabilitiesAndStockholdersEquity': 222374000, 'remainder_NetIncome': -4170000, 'remainder_Revenues': 447177000, 'obs_EconomicCapitalRatio': nan}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001029142')"}
info Ambiguous non-comprehensive roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'balance', 'non_comprehensive_roles': {'100030 - Statement - Consolidated Balance Sheets 2': 19, '100010 - Statement - Consolidated Balance Sheets': 13}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Edgar->Model Mapping